Laurence E. Burgess,Christopher T. Clark,Adam Cook,Christopher P. Corrette,Robert Kirk DeLisle,George A. Doherty,Kevin W. Hunt,Todd T. Romoff,Ganghyeok Kim
申请号：
US14231356
公开号：
US09096567B2
申请日:
2014.03.31
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Provided herein is a method of treating an allergic inflammatory disease selected from asthma, dermatitis, allergic rhinitis, urticaria, anaphylaxis, angioedemea, allergies, contact hypersensitivity, drug hypersensitivity, and allergic conjunctivitis in a mammal, comprising administering a therapeutically effective amount of a compound of Formula Ior a pharmaceutically acceptable salt thereof, to said mammal in need thereof, wherein A1, A2, W, L, G, R7a, R7b, R8, R9 and R10 are as defined herein.
